ADC.AU ACDC Metals Ltd
Closed Easter Monday 04-17 16:12:00 AEST
0.04
+0.00
0.00%
| High0.04 | Low0.04 | Vol0.00 |
| Open0.04 | D1 Closing0.04 | Amplitude0.00% |
| Mkt Cap3.00M | Tradable Cap1.61M | Total Shares73.28M |
| T/O0.00 | T/O Rate0.00% | Tradable Shares39.34M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
Dominari Holdings reports preliminary 2024 revenue of $19M, up 900%
Grafa · 03-28
Dominari Holdings reports preliminary 2024 revenue of $19M, up 900%
Shandong Boan Biotechnology Cancer Drug Granted U.S. FDA Orphan Drug Designation
MT Newswires Live · 03-27
Otsuka's Taiho to Buy Swiss ADC Developer Araris Biotech
MT Newswires Live · 03-18
CStone Pharmaceuticals Submit Clinical Trial Application in Australia for Cancer Drug
MT Newswires Live · 03-06
ArriVent hits trial milestone, closes 2024 with $266.5M cash
Grafa · 03-03
ArriVent hits trial milestone, closes 2024 with $266.5M cash
Sichuan Biokin Pharmaceutical Enrolls First Patient for Lung Cancer Trial; Shares Down 4%
MT Newswires Live · 03-03
Coles share price lifts off on dividend boost
MotleyFool · 02-26
AstraZeneca's Datroway get FDA nod for breast cancer treatement
Grafa · 01-21
AstraZeneca's Datroway get FDA nod for breast cancer treatement
Sichuan Kelun-Biotech Biopharmaceutical Gets NMPA's Nod for Solid Tumors Drug
MT Newswires Live · 01-21
Market Chatter: Samsung Biologics Ventures in Antibody-Drug Conjugate Market with New Facility
MT Newswires Live · 01-17
Samsung Biologics Expands ADC Collaboration with LigaChem Biosciences
MT Newswires Live · 01-10
FDA grants breakthrough therapy designation to GSK's osteosarcoma drug
Grafa · 01-07
FDA grants breakthrough therapy designation to GSK's osteosarcoma drug
Agree Realty Expects to Invest Up to $1.3 Billion in 2025
MT Newswires Live · 01-06
Innovent Bio Grants Roche Exclusive Global Rights to ADC Targeting DLL3
MT Newswires Live · 01-02
IDEAYA inks $1.045B licensing deal with Hengrui for cancer therapy
Grafa · 2024-12-30
IDEAYA inks $1.045B licensing deal with Hengrui for cancer therapy
Aadi Bioscience shares jump on licensing agreement for cancer drugs
Grafa · 2024-12-20
Aadi Bioscience shares jump on licensing agreement for cancer drugs
Is the Coles share price a buy amid its 2025 outlook?
MotleyFool · 2024-12-12
Trump Media saw the largest increase in short interest in October
seekingalpha · 2024-11-20
Trump Media saw the largest increase in short interest in October
BRIEF-Coles Update On Supply Chain Modernisation
Reuters · 2024-10-31
Coles share price climbs on Q1 update and $880m investment news
MotleyFool · 2024-10-30
Introduction
Company Name.
ACDC Metals Ltd
Affiliated Markets:
ASX
Listing Date:
--
Main Business:
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App